CN102631644A - External-use traditional Chinese medicine for treating myositis ossificans - Google Patents

External-use traditional Chinese medicine for treating myositis ossificans Download PDF

Info

Publication number
CN102631644A
CN102631644A CN2012101412974A CN201210141297A CN102631644A CN 102631644 A CN102631644 A CN 102631644A CN 2012101412974 A CN2012101412974 A CN 2012101412974A CN 201210141297 A CN201210141297 A CN 201210141297A CN 102631644 A CN102631644 A CN 102631644A
Authority
CN
China
Prior art keywords
parts
chinese medicine
rhizoma
external
myositis ossificans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012101412974A
Other languages
Chinese (zh)
Other versions
CN102631644B (en
Inventor
严婉力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Guyuantang Health Industry Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012101412974A priority Critical patent/CN102631644B/en
Publication of CN102631644A publication Critical patent/CN102631644A/en
Application granted granted Critical
Publication of CN102631644B publication Critical patent/CN102631644B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to an external-use traditional Chinese medicine for treating myositis ossificans. The external-use traditional Chinese medicine comprises the following medicinal materials by weight part: 4-6 parts of flowers carthami, 20-30 parts of rhizoma sparganii, 20-30 parts of curcuma zedoary, 4-6 parts of frankincense, 4-6 parts of myrrh, 20-30 parts of Chinese elder, 20-30 parts of cape jasmine, 40-60 parts of coptis chinensis, 40-60 parts of golden cypress and 40-60 parts of radix sophorae flavescentis. According to the experiment, the external-use traditional Chinese medicine can treat myositis ossificans effectively and safely.

Description

A kind of external Chinese medicine of treating myositis ossificans
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of external Chinese medicine of treating myositis ossificans.
Background technology
Myositis ossificans is meant that calcification has taken place the tissue of normal no calcification, also cries ectopic ossification.Myositis ossificans is because after intraarticular or juxtra-articular fracture, dislocate, or after the dislocation soon, periosteum again with bone photo company before, carry out passive and powerful activity prematurely, make due to proliferation of fibrous tissue, the osseous metaplasia.Be mainly in the muscle place at positions such as joint, quadriceps femoris, adductor, upper arm flesh, little, buttocks, knee joint, shoulder, elbow.
Still lack medicine at present.Therefore the Chinese medicine of researching and developing a kind of safe and effective treatment and prevention myositis ossificans is very with practical value.
The present Research of the related medical material of Chinese medicine of the present invention is following:
These article of Flos Carthami [source] are the dried floral of feverfew Flos Carthami Carthamus tinctorius L..[function cures mainly] promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain.Be used for amenorrhea, dysmenorrhea, lochia is not all right, the lump in the abdomen mass in the abdomen, injury from falling down, skin infection swells and ache.
Triangular [source] these article are the dry tuber of Sparganiaceae plant rhizoma scirpi Sparganium stoloniferum Buch.-Ham..The circulation of qi promoting of [function cures mainly] removing blood stasis, the removing food stagnancy pain relieving.Be used for the lump in the abdomen mass in the abdomen, blood stasis amenorrhea, food stagnation distending pain.
These article of Rhizoma Curcumae [source] are the dry rhizome of zingiberaceous plant Rhizoma Curcumae Curcuma phaeocaulis Val., Guangxi zedoary Curcuma Kwangsiensis S. G.Lee et C. F. Liang or RADIX CURCUMAE Curcuma wenyujin Y.H. Chen et C. Ling.[function cures mainly] circulation of qi promoting removing blood stasis, the removing food stagnancy pain relieving.For Dan Jia lump, bleeding, amenorrhea, food plot pain; early cervical cancer.
Olibanum [source] Burseraceae Boswellia carterii platymiscium Boswellia carterii Boswellia carterii Birdw. [B. sacra Fluek.], medicine glue XIANGSHU B. bhawdajiana Birdw. and wild Boswellia carterii B. neglecta M. Moore etc. are used as medicine with the oleo-gum-resin that its trunk skin zone wound oozes out.[function cures mainly] promoting blood circulation and stopping pain.Be used for all pains of trusted subordinate, the contracture of muscle arteries and veins, traumatic injury, sore, carbuncle and painful swelling; The externally used detumescence granulation promoting.
Myrrha [source] Burseraceae bdellium plant myrrh Commiphora myrrha Engl. [C. molmol Engl.] and belong to the oleo-gum-resin that the trunk skin zone of his kind of plant oozes out together.[function cures mainly] eliminating stasis to stop pain, the externally used detumescence granulation promoting.Be used for traumatic injury congestion and swell and ache, ulcer sore pain, all pains of breast abdomen; External is controlled the open sore part and is not restrained for a long time.
These article of the Pseudobulbus Bletillae (Rhizoma Bletillae) [source] are the dry tuber of orchid Pseudobulbus Bletillae (Rhizoma Bletillae) Bletilla striata (Thunb.) Reichb. f..[function cures mainly] astringing to arrest bleeding, detumescence and promoting granulation.Be used for hemoptysis and spit blood traumatic hemorrhage, sore swollen toxin, chapped skin; The pulmonary tuberculosis hemoptysis, ulcer haemorrhage.
These article of Fructus Gardeniae [source] are the dry mature fruit of Maguireothamnus speciosus Fructus Gardeniae Gardenia jasminoides Ellis.[function cures mainly] fruit: pathogenic fire purging relieving restlessness, clearing away heat and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body.It is vexed to be used for calentura, the jaundice dark coloured urine, and blood strangury and dry pain, heat in blood is told nosebleed, conjunctival congestion and swelling pain, pathogenic fire,toxin and furuncles; External treatment bruise pain.
These article of Rhizoma Coptidis [source] are the dry rhizome of ranunculaceae plant Rhizoma Coptidis Coptis chinensis Franch., Coptis deltoidea C.Y.Cheng et Hsiao Coptis deltoidea C. Y. Cheng et Hsiao or Coptis Teeta Wall Coptis teeta Wall..[function cures mainly] heat clearing and damp drying, eliminating fire and detoxication.Be used for damp and hot feeling of fullness, the vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, the carbuncle furuncle is quenched one's thirst in toothache; External treatment eczema, eczema, auditory meatus is suppurated.The kind clear part of the body cavity above the diaphragm housing the heart and lungs of Rhizoma Coptidis (processed with wine) is burning hot.Be used for conjunctival congestion, aphtha.Prepared RHIZOMA COPTIDIS with rhizoma zingiberis recens juice clearing stomach stomach function regulating preventing or arresting vomiting.Be used for cold and heat and tie mutually, damp and hot middle resistance, feeling of fullness vomiting.Cornel Rhizoma Coptidis soothing liver-QI stomach function regulating preventing or arresting vomiting.Be used for incoordination between the liver and stomach, the vomiting acid regurgitation.
These article of Cortex Phellodendri [source] are the dry bark of rutaceae wampee Phellodendron chinense Schneid. or Cortex Phellodendri Phellodendron amurense Rupr..[function cures mainly] heat clearing and damp drying, pathogenic fire purging are removed and are steamed, and skin ulcer is treated in detoxifcation.Be used for damp-heat dysentery, jaundice, leukorrhagia, pyretic stranguria, beriberi, flaccidity { is warded off }, hectic fever due to YIN-deficiency consumptive fever, night sweat, seminal emission, sore swollen toxin, eczema pruritus.The stir-baked CORTEX PHELLODENDRI with salt solution nourishing YIN to lower pathogenic fire.Be used for hyperactivity of fire caused by deficiency of YIN, the night sweat hectic fever due to YIN-deficiency.
These article of Radix Sophorae Flavescentis [source] are the dry root of leguminous plant Radix Sophorae Flavescentis Sophora flavescens Ait..[function cures mainly] heat clearing and damp drying, parasite killing, diuresis.Be used for hematodiarrhoea, have blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy; External treatment trichomonal vaginitis.
Summary of the invention
The present invention aims to provide a kind of external Chinese medicine of treating myositis ossificans, through selecting suitable medical material and proportioning thereof, reaches the purpose of safe and effective healing laryngopharynx swelling and pain.
In order to achieve the above object, the present invention adopts following technical scheme:
A kind of external Chinese medicine of treating myositis ossificans; It is characterized in that it is made up of following medicinal materials in part by weight: Flos Carthami 4-6 part, triangular 20-30 part, Rhizoma Curcumae 20-30 part, Olibanum 4-6 part, Myrrha 4-6 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 part, Fructus Gardeniae 20-30 part, Rhizoma Coptidis 40-60 part, Cortex Phellodendri 40-60 part, Radix Sophorae Flavescentis 40-60 part.
Wherein preferred: 5 parts on Flos Carthami, triangular 25 parts, 25 parts of Rhizoma Curcumae, 5 parts of Olibanums, 5 parts of Myrrhas, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 25 parts of Fructus Gardeniaes, 50 parts of Rhizoma Coptidis, 50 parts of Cortex Phellodendris, 50 parts of Radix Sophorae Flavescentiss.
Below in conjunction with theory of Chinese medical science the beneficial effect that we are bright is described:
The inventor finds in practice process, myositis ossificans be because of the wound stasis of blood stagnate, qi-blood disharmony due to, so treatment should be main with blood circulation promoting and blood stasis dispelling, clearing away heat and alleviating pain.The present invention uses Flos Carthami, triangular, Rhizoma Curcumae, Olibanum, Myrrha promoting blood circulation, removing blood stasis and relieving pain; Fructus Gardeniae, Rhizoma Coptidis, Cortex Phellodendri, Radix Sophorae Flavescentis, heat-clearing and toxic substances removing; Pseudobulbus Bletillae (Rhizoma Bletillae) convergence granulation promoting; All medicines share, blood circulation promoting and blood stasis dispelling, clearing away heat and alleviating pain, thereby treatment and prevention myositis ossificans.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
The inventor collects the out-patient of 75 routine myositis ossificans altogether between year April in October, 2009-2010, wherein male 43 examples, women 32 examples, age 12-45 year, the course of disease 2 days-3 years.Be divided at random: 50 examples are organized in treatment, matched group 25 examples.Data there was no significant differences such as two groups of sexes, age have comparability.
2, test method
Matched group is coated with Moschus blood-circulation and removing blood stasis ointment, every day 2-4 time outside the affected part.1 week of the course of treatment.
The sweet unguentum obliterating affected part that the treatment group uses optimization formula of the present invention to make according to specific embodiment 1, every day 2-4 time.1 week of the course of treatment.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and the test chamber inspection is normal.Take a turn for the better: clinical symptom relief, lab testing improve or are normal.Invalid: clinical symptoms does not have being clearly better or increases the weight of.
3.2 table 1 is seen in treatment statistical result.
Table 1 liang group curative effect relatively
Group n Recovery from illness Take a turn for the better Invalid The untoward reaction example Total effective rate (%)
The treatment group 50 6 42 2 0(0%) 96%
Matched group 25 2 10 13 0(0%) 48%
It is thus clear that the medicine that the preferred embodiment for the present invention makes can safe and effective treatment myositis ossificans.
According to above-mentioned clinical experiment data; Treat the Chinese medicine Analysis on Mechanism and the general knowledge known in this field of myositis ossificans in conjunction with the present invention; Those skilled in the art know by inference easily; Medical material among utilization the present invention; Near value optimum weight part in the scope of " Flos Carthami 4-6 part, triangular 20-30 part, Rhizoma Curcumae 20-30 part, Olibanum 4-6 part, Myrrha 4-6 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 part, Fructus Gardeniae 20-30 part, Rhizoma Coptidis 40-60 part, Cortex Phellodendri 40-60 part, Radix Sophorae Flavescentis 40-60 part ", can obtain the medicine similar techniques effect that makes with the preferred embodiment for the present invention at least.
The specific embodiment
In order to understand better and embodiment of the present invention, further specify the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take by weighing 5 parts on Flos Carthami, triangular 25 parts, 25 parts of Rhizoma Curcumae, 5 parts of Olibanums, 5 parts of Myrrhas, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 25 parts of Fructus Gardeniaes, 50 parts of Rhizoma Coptidis, 50 parts of Cortex Phellodendris, 50 parts of Radix Sophorae Flavescentiss; Add 8 times of water gagings, decocted 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate concentrates, and drying is ground into powdery, adds proper honey and is in harmonious proportion, and promptly gets sweet unguentum.
Be used to treat myositis ossificans.Get an amount of obliterating affected part, every day 2-4 time.
Specific embodiment 2
Take by weighing 4 parts on Flos Carthami, triangular 20 parts, 20 parts of Rhizoma Curcumae, 4 parts of Olibanums, 4 parts of Myrrhas, 20 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 20 parts of Fructus Gardeniaes, 40 parts of Rhizoma Coptidis, 40 parts of Cortex Phellodendris, 40 parts of Radix Sophorae Flavescentiss; Add 10 times of water gagings, decocted 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate concentrates, and drying is ground into powdery, adds proper honey and is in harmonious proportion, and promptly gets sweet unguentum.
Be used to treat myositis ossificans.Get an amount of obliterating affected part, every day 2-4 time.
Specific embodiment 3
Take by weighing 6 parts on Flos Carthami, triangular 30 parts, 30 parts of Rhizoma Curcumae, 6 parts of Olibanums, 6 parts of Myrrhas, 30 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 30 parts of Fructus Gardeniaes, 60 parts of Rhizoma Coptidis, 60 parts of Cortex Phellodendris, 60 parts of Radix Sophorae Flavescentiss; Add 6 times of water gagings, decoct 3 times, decocted 1 hour at every turn, merge decoction liquor, concentrate, drying is ground into powdery, adds proper honey and is in harmonious proportion, and promptly gets sweet unguentum.
Be used to treat myositis ossificans.Get an amount of obliterating affected part, every day 2-4 time.

Claims (2)

1. external Chinese medicine of treating myositis ossificans; It is characterized in that it is made up of following medicinal materials in part by weight: Flos Carthami 4-6 part, triangular 20-30 part, Rhizoma Curcumae 20-30 part, Olibanum 4-6 part, Myrrha 4-6 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 part, Fructus Gardeniae 20-30 part, Rhizoma Coptidis 40-60 part, Cortex Phellodendri 40-60 part, Radix Sophorae Flavescentis 40-60 part.
2. according to the external Chinese medicine of the described treatment myositis ossificans of claim 1; It is characterized in that it is made up of following medicinal materials in part by weight: 5 parts on Flos Carthami, triangular 25 parts, 25 parts of Rhizoma Curcumae, 5 parts of Olibanums, 5 parts of Myrrhas, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 25 parts of Fructus Gardeniaes, 50 parts of Rhizoma Coptidis, 50 parts of Cortex Phellodendris, 50 parts of Radix Sophorae Flavescentiss.
CN2012101412974A 2012-05-09 2012-05-09 External-use traditional Chinese medicine for treating myositis ossificans Active CN102631644B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101412974A CN102631644B (en) 2012-05-09 2012-05-09 External-use traditional Chinese medicine for treating myositis ossificans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101412974A CN102631644B (en) 2012-05-09 2012-05-09 External-use traditional Chinese medicine for treating myositis ossificans

Publications (2)

Publication Number Publication Date
CN102631644A true CN102631644A (en) 2012-08-15
CN102631644B CN102631644B (en) 2013-12-04

Family

ID=46616328

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101412974A Active CN102631644B (en) 2012-05-09 2012-05-09 External-use traditional Chinese medicine for treating myositis ossificans

Country Status (1)

Country Link
CN (1) CN102631644B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104971244A (en) * 2015-06-29 2015-10-14 程明国 Externally-used medicine for treating myositis ossificans
CN104998102A (en) * 2015-06-29 2015-10-28 苗光丽 Externally applied drug for preventing myositis ossificans after elbow fracture
CN105031320A (en) * 2015-06-29 2015-11-11 李克军 Method for preparing externally applied medicament for myositis ossificans
CN112826906A (en) * 2021-01-21 2021-05-25 陈小萍 Antiviral transdermal drug and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101297946A (en) * 2008-06-24 2008-11-05 孙兆印 Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof
CN102085283A (en) * 2009-12-03 2011-06-08 吴延义 Traditional Chinese medicament for treating myositis ossificans

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101297946A (en) * 2008-06-24 2008-11-05 孙兆印 Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof
CN102085283A (en) * 2009-12-03 2011-06-08 吴延义 Traditional Chinese medicament for treating myositis ossificans

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
徐翔等: "中药内服外洗治疗肘关节骨化性肌炎21例", 《安徽中医临床杂志》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104971244A (en) * 2015-06-29 2015-10-14 程明国 Externally-used medicine for treating myositis ossificans
CN104998102A (en) * 2015-06-29 2015-10-28 苗光丽 Externally applied drug for preventing myositis ossificans after elbow fracture
CN105031320A (en) * 2015-06-29 2015-11-11 李克军 Method for preparing externally applied medicament for myositis ossificans
CN112826906A (en) * 2021-01-21 2021-05-25 陈小萍 Antiviral transdermal drug and preparation method thereof

Also Published As

Publication number Publication date
CN102631644B (en) 2013-12-04

Similar Documents

Publication Publication Date Title
CN102631644B (en) External-use traditional Chinese medicine for treating myositis ossificans
CN102631454B (en) Externally used traditional Chinese medicine for curing fracture postoperation synarthrophysis
CN102657797B (en) Traditional Chinese medicine for treating female leukorrheal diseases
CN103800759B (en) One treats person in middle and old age's rheumatism, rheumatoid Chinese medicine
CN1296076C (en) Medicine for clearing skin toxin
CN103656323A (en) Traditional Chinese medicine for treating erythroderma-type psoriasis
CN103705614B (en) Traditional Chinese medicine for treating herpes zoster
CN104491456A (en) Impediment eliminating and collateral dredging paste for knee joint rheumatic arthritis and preparation
CN103520594B (en) Traditional Chinese medicine for treating interior dampness-heat syndrome type acne disease
CN103520570A (en) Traditional Chinese medicine for treating liver depression forming fire syndrome type acne disease
CN103610784B (en) Traditional Chinese medicine for treating periodontal abscess
CN103520631B (en) Traditional Chinese medicine used for treating irregular menstruation
CN104666541A (en) Traditional Chinese medicine for treating acute typical intestinal amebiasis
CN103566226B (en) Traditional Chinese medicament for treating suppurative pneumonia
CN103536741B (en) External-use Chinese medicine for prompting anal fistula postoperative recovery
CN102908450B (en) Traditional Chinese medicine for treating nutritional edema
CN103638506B (en) A kind of Chinese medicine for the treatment of arthromyodynia
CN103705819B (en) A kind of Chinese medicine treating intestinal Behcet disease
CN103610815B (en) A kind of Chinese medicine for the treatment of cellulitis
CN103520568B (en) A kind of Chinese medicine for the treatment of the qi depression to blood stasis pattern of syndrome thoracic obstruction
CN103933515A (en) Traditional Chinese medicine for treating prostatitis and preparation method thereof
CN103893366B (en) A kind of Chinese medicinal granule and method of inspection thereof being used for the treatment of cerebral ischemia
CN103285361B (en) Traditional Chinese medicine for treating horse orchitis
CN103623281B (en) Traditional Chinese medicine for treating infantile hyperpyrexia
CN103735699A (en) Traditional Chinese medicinal composition for treating scald and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220119

Address after: 712000 Jianchi plant of American science and Technology Industrial Park, Yongle Town, Jinghe new town, Xixian new area, Xi'an, Shaanxi

Patentee after: Shaanxi guyuantang Health Industry Co.,Ltd.

Address before: 264000 Yantai Hospital of traditional Chinese medicine, 39 happiness Road, Zhifu District, Shandong, Yantai

Patentee before: Yan Wanli